City of Hope Atlanta opens Blood and Marrow Transplantation and Cell Therapy Program

Engineered HSV can trigger genetic chain reaction, rearrange HSV genes during co-infection

In preclinical work recently published in Nature Communications, Fred Hutchinson Cancer Center scientists used a genetic “chain reaction” to transform herpes simplex virus DNA during an HSV infection.

November 15, 2024

Vol.50 No.43

In Brief

Anthony Stack joins Fox Chase as assistant professor in bone marrow transplant and cellular therapies

Anthony Stack has joined Fox Chase Cancer Center as an assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies.

September 27, 2024

Vol.50 No.36

In Brief

Tampa General, Mass General Brigham strengthen relationship through BMT, CAR T collaboration

Tampa General Hospital and Mass General Brigham announced a strengthening of their affiliation with the development of new programs and services, including a bone marrow transplant program and CAR T therapy program, at TGH.

September 20, 2024

Vol.50 No.35

In Brief

MD Anderson and industry partners to conduct T cell studies on the International Space Station

The University of Texas MD Anderson Cancer Center and collaborators are initiating a research project that will send T cells to the International Space Station to study the effects of prolonged microgravity on cell differentiation, activation, memory, and exhaustion.

August 02, 2024

Vol.50 No.31

In Brief

A. Samer Al-Homsi named system chief of blood and marrow transplant and cellular therapy at Northwell

A. Samer Al-Homsi, a leader in hematology, was appointed as system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute.

March 29, 2024

Vol.50 No.13

Clinical

First-ever commercial TIL therapy: How NCI, Iovance, and Moffitt achieved FDA approval

In a major breakthrough in cellular therapy, FDA has approved the first tumor-infiltrating lymphocyte therapy for patients with unresectable or metastatic melanoma who have received prior treatment, including with checkpoint inhibitors.

February 23, 2024

Vol.50 No.08

By Matthew Bin Han Ong

City of Hope Atlanta opens Blood and Marrow Transplantation and Cell Therapy Program

YOU MAY BE INTERESTED IN

Engineered HSV can trigger genetic chain reaction, rearrange HSV genes during co-infection

Anthony Stack joins Fox Chase as assistant professor in bone marrow transplant and cellular therapies

Tampa General, Mass General Brigham strengthen relationship through BMT, CAR T collaboration

MD Anderson and industry partners to conduct T cell studies on the International Space Station

A. Samer Al-Homsi named system chief of blood and marrow transplant and cellular therapy at Northwell

First-ever commercial TIL therapy: How NCI, Iovance, and Moffitt achieved FDA approval

Renew today!

Subscriber content

Never miss an issue!

Login